Posted: February 26, 2008

Arrowhead Conferences' 2nd Annual Drug Delivery Summit to Take Place May 1st-2nd, 2008

(Nanowerk News) Arrowhead Publishers and Conferences is proud to announce that it is hosting its 2nd Annual Drug Delivery Summit: New Technologies and Commercialization Trends in San Francisco, California on May 1st and 2nd, 2008.
Background and Focus:
As competition in the pharmaceutical marketplace grows, companies are increasingly looking towards the drug delivery industry to maximize revenues and combat generic competitors. The drug delivery industry has in recent years become a key partner for pharmaceutical companies in their efforts to maximize the patent lives of successful products. Drug delivery companies not only stand to benefit from patent expiry by providing their reformulation services to pharmaceutical companies, but also by producing their own versions of branded products with improved delivery mechanisms.The current value of the drug delivery market has been estimated at over USD$65 billion.
Arrowhead's 2nd Annual Drug Delivery Summit will provide a forum for leaders from both the drug delivery and pharmaceutical industry to discuss the challenges and opportunities facing the development of new drug delivery technologies and therapies utilizing cutting-edge drug delivery technologies. This conference will not only assess new drug delivery systems and technologies, but will provide instruction and case studies on successful licensing and deal-making in this sector.
With sessions covering both the technical and business sides of the industry, this conference has been organized with both the scientist and business professional in mind.
Key themes of this conference will include:
  • An examination of key emerging technologies in the following areas:
  • - injectable

    - ultrasonic

    - electroporation

    - inhalable

    - transdermal

    - transmucosal

    - nanotechnology

    - controlled release

    - RNAi delivery

    - and other modes of drug delivery

  • Keys to the formation of successful alliances
  • Unlocking the door to delivery of macromolecules
  • Mapping of bioavailability as a key to successful formulation
  • Overcoming first pass metabolism and absorption window problems
  • Patent and IP protection in drug delivery
  • Considerations and best practices in contract manufacturer-drug delivery partnerships
  • Trends in tumor and organ targeting
  • Making the deal - structuring mutually beneficial licensing arrangements
  • For more information about this conference, please visit
    Source: Arrowhead Publishers and Conferences
    Subscribe to a free copy of one of our daily
    Nanowerk Newsletter Email Digests
    with a compilation of all of the day's news.
    These articles might interest you as well: